Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 3/20 | 0.31 |
| ▸ | CNR1 | P21554 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16592328 | 0.90 | CNR1 (0.36) | CNR2CNR1 | |
| SCHEMBL16592323 | 0.90 | CNR1 (0.34) | CNR2CNR1 | |
| SCHEMBL16585701 | 0.89 | CNR1 (0.36) | TSHRCNR2CNR1 | |
| SCHEMBL16562417 | 0.84 | ALDH1A1 (0.32) | TSHR | |
| SCHEMBL16562399 | 0.84 | TSHR (0.35) | POLBTSHRCNR1 | |
| SCHEMBL16592233 | 0.79 | POLB (0.32) | POLBCNR2CNR1 | |
| Pinoxaden SCHEMBL64416 | 0.78 | ELANE (0.33) | TSHRCNR2CNR1RAB9ACYP1A2 | |
| Pinoxaden SCHEMBL29359629 | 0.78 | ELANE (0.33) | TSHRCNR2CNR1RAB9ACYP1A2 | |
| SCHEMBL13672448 | 0.76 | CNR1 (0.38) | POLBTSHRCNR2CNR1 | |
| SCHEMBL16592332 | 0.76 | ELANE (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160219881-A1 | HERBICIDALLY ACTIVE 2-HALOGEN-4-ALKYNYL-PHENYL-PYRAZOLIDINE-DIONE OR PYRROLIDINE-DIONE DERIVATIVES | SYNGENTA LIMITED (GB) | 2016-08-04 | — | — | US | disclosed |
| US-20160219881-A1 | HERBICIDALLY ACTIVE 2-HALOGEN-4-ALKYNYL-PHENYL-PYRAZOLIDINE-DIONE OR PYRROLIDINE-DIONE DERIVATIVES | SYNGENTA LIMITED (GB) | 2016-08-04 | — | — | US | disclosed |
| WO-2015040114-A1 | HERBICIDALLY ACTIVE 2-HALOGEN-4-ALKYNYL-PHENYL-PYRAZOLIDINE-DIONE OR PYRROLIDINE-DIONE DERIVATIVES | SYNGENTA LIMITED (GB) | 2015-03-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160219881-A1 | HERBICIDALLY ACTIVE 2-HALOGEN-4-ALKYNYL-PHENYL-PYRAZOLIDINE-DIONE OR PYRROLIDINE-DIONE DERIVATIVES | CBR3, CBR1, CNPY2 | POLB 3852/4885TSHR 973/4885CNR2 304/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.